Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, which is approved by the FDA in ovarian cancer, and Jemperli for ...
In 2024, the American Cancer Society estimates that uterine cancer will surpass ovarian cancer in total estimated number of deaths in the United States. That’s partly due to the progress made in ...
Ian C. Cook, MD, discusses the feasibility and benefits of adding bilateral salpingectomy to nongynecologic surgery.
A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using ...
As part of the CURE® Educated Patient® Gynecologic Cancers Summit, an expert explained the basics of biomarkers and the questions they raise. Patients can benefit from clinical trials in gynecologic ...
Dr. Jessica Ritch is a board-certified, fellowship-trained gynecologist who is passionate about helping women feel better, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback